Summary:
Procter & Gamble Hygiene and Health Care reported a 6.68 per cent decline in Q2 FY27 net profit to Rs 195.84 crore, compared with Rs 209.86 crore a year earlier, while revenue slipped marginally to Rs 1,145 crore. Higher raw material and energy costs, commodity price fluctuations and unfavourable foreign exchange movements affected profitability, although productivity initiatives helped offset some of the pressure. The company continued investing in innovation and promotional activities, while its H1 FY27 revenue declined 2 per cent to Rs 2,063 crore.
Procter & Gamble Hygiene and Health Care Ltd on Thursday announced a 6.68 per cent year-on-year fall in profit after tax to Rs 195.84 crore for the September quarter of FY27, citing rising raw material expenses and adverse commodity price movements.
The company had recorded a net profit of Rs 209.86 crore during the same quarter of the previous financial year, according to its regulatory disclosure.
Revenue from operations edged down to Rs 1,145 crore in the September quarter of FY27, from Rs 1,150.17 crore in the year-ago period.
The FMCG company stated that its profitability faced a double-digit impact during the quarter due to volatility in commodity prices, higher raw material and energy expenses, and unfavourable foreign exchange movements.
However, the impact was partly mitigated through its strong productivity initiatives.
The company also said it continued to increase spending on innovation, advertising and promotional activities compared with the previous quarter, with the aim of strengthening its long-term competitiveness and generating value.
PGHH, a listed subsidiary of Procter & Gamble India, has operations in the healthcare and feminine care categories, with popular brands such as Vicks and Whisper in its portfolio.
The multinational company’s overall expenses increased 2.47 per cent year-on-year to Rs 900 crore during the September quarter.
For the first six months (H1) of FY27, the company’s total revenue declined marginally by 2 per cent to Rs 2,063 crore.
Shares of Procter & Gamble Hygiene and Health Care Ltd ended unchanged at Rs 7,200 per share on the BSE.
Related posts:
US Medical Costs Spark Online Debate After Comparison With India’s Healthcare Expenses
Primary Healthcare: The Foundation of India’s Healthcare System
Assam’s MMR Drops Below National Average as India’s Healthcare Advances Over the Past Decade: VP
Krishnamoorthi and Smith Propose Bills to Strengthen the Immigrant Healthcare Workforce
Private equity funding in the healthcare sector surges 621% to $3.1 billion
